Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2014

01-02-2014 | Article

Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting

Authors: A. Abdul Wahab, S. J. Taj-Aldeen, F. Hagen, S. Diophode, A. Saadoon, J. F. Meis, C. H. Klaassen

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2014

Login to get access

Abstract

Pseudomonas aeruginosa is one of the primary pathogens in patients with cystic fibrosis (CF) and a major cause of morbidity and mortality. Reports of the spread of epidemic or transmissible strains of P. aeruginosa within and across CF centers raised the possibility of clonal spread among siblings with CF. This work reports the genotypic relatedness of P. aeruginosa in CF patients with the CFTR I1234V mutation, and to determine whether the genotypes are identical among CF siblings and among different families with the same CFTR mutation. Sixty-six P. aeruginosa isolates were obtained from sputa/deep-pharyngeal swabs from 27 CF patients belonging to 17 families. Genotypic relatedness was assessed using amplified fragment-length polymorphism (AFLP) fingerprinting. Twenty-three distinct genotypes of P. aeruginosa were identified. Eleven families each had one distinct genotype. In the other 6 families more than one genotype was observed; 3 families each showed two genotypes, 2 families each had three genotypes and 1 family had four genotypes of P. aeruginosa. In several cases, siblings with CF from the same family harbored the same strain of P. aeruginosa, which were different from the genotypes in other families. On the other hand, there was an overlap in P. aeruginosa between closely related families. Some patients show persistent colonization with the same genotype of P. aeruginosa over the longitudinal period. The presence of the same genotypes in siblings of the same family and closely related families suggests cross-transmission of P. aeruginosa or acquisition from common environmental exposure.
Literature
1.
go back to reference Jacques J, Derelle J, Weber M, Vidailhet M (1998) Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur J Pediatr 157:427–431PubMedCrossRef Jacques J, Derelle J, Weber M, Vidailhet M (1998) Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur J Pediatr 157:427–431PubMedCrossRef
2.
go back to reference Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918–951PubMedCrossRef Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918–951PubMedCrossRef
3.
go back to reference Collins J, Farrell PM (2001) Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 32:277–287PubMedCrossRef Collins J, Farrell PM (2001) Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 32:277–287PubMedCrossRef
4.
go back to reference Henry RL, Mellis CM, Petrovic L (1992) Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 12:158–161PubMedCrossRef Henry RL, Mellis CM, Petrovic L (1992) Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 12:158–161PubMedCrossRef
5.
go back to reference Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML (2005) Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293:581–588PubMedCrossRef Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML (2005) Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293:581–588PubMedCrossRef
6.
go back to reference Fegan M, Francis P, Hayward AC, Davis GH, Fuerst JA (1990) Phenotypic conversion of Pseumonas aeruginosa in cystic fibrosis. J Clin Microbiol 28:1143–1146PubMedCentralPubMed Fegan M, Francis P, Hayward AC, Davis GH, Fuerst JA (1990) Phenotypic conversion of Pseumonas aeruginosa in cystic fibrosis. J Clin Microbiol 28:1143–1146PubMedCentralPubMed
7.
go back to reference Jones AM, Dodd ME, Morris J, Doherty C, Govan JR, Webb AK (2010) Clinical outcome for cystic fibrosis patients infected with transmissible Pseudomonas aeruginosa: an 8-year prospective study. Chest 137:1405–1409PubMedCrossRef Jones AM, Dodd ME, Morris J, Doherty C, Govan JR, Webb AK (2010) Clinical outcome for cystic fibrosis patients infected with transmissible Pseudomonas aeruginosa: an 8-year prospective study. Chest 137:1405–1409PubMedCrossRef
8.
go back to reference Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ (2004) Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 59:334–336PubMedCrossRef Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ (2004) Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 59:334–336PubMedCrossRef
9.
go back to reference Qin X, Emerson J, Stapp J, Stapp L, Abe P, Burns JL (2003) Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol 41:4312–4317PubMedCentralPubMedCrossRef Qin X, Emerson J, Stapp J, Stapp L, Abe P, Burns JL (2003) Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol 41:4312–4317PubMedCentralPubMedCrossRef
10.
go back to reference Wellinghausen N, Köthe J, Wirths B, Sigge A, Poppert S (2005) Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol 43:4070–4075PubMedCentralPubMedCrossRef Wellinghausen N, Köthe J, Wirths B, Sigge A, Poppert S (2005) Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol 43:4070–4075PubMedCentralPubMedCrossRef
11.
go back to reference Kidd TJ, Ramsay KA, Hu H, Bye PT, Elkins MR, Grimwood K, Harbour C, Marks GB, Nissen MD, Robinson PJ, Rose BR, Sloots TP, Wainwright CE, Bell SC (2009) Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients. J Clin Microbiol 47:1503–1509PubMedCentralPubMedCrossRef Kidd TJ, Ramsay KA, Hu H, Bye PT, Elkins MR, Grimwood K, Harbour C, Marks GB, Nissen MD, Robinson PJ, Rose BR, Sloots TP, Wainwright CE, Bell SC (2009) Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients. J Clin Microbiol 47:1503–1509PubMedCentralPubMedCrossRef
12.
go back to reference Kidd TJ, Grimwood K, Ramsay KA, Rainey PB, Bell SC (2011) Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. J Clin Microbiol 49:263–268PubMedCentralPubMedCrossRef Kidd TJ, Grimwood K, Ramsay KA, Rainey PB, Bell SC (2011) Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. J Clin Microbiol 49:263–268PubMedCentralPubMedCrossRef
13.
go back to reference Abdul Wahab A, Al Thani G, Dawod ST, Kambouris M, Al Hamed M (2001) Heterogeneity of the cystic fibrosis phenotype in a large kindred family in Qatar with cystic fibrosis mutation (I1234V). J Trop Pediatr 47:110–112PubMed Abdul Wahab A, Al Thani G, Dawod ST, Kambouris M, Al Hamed M (2001) Heterogeneity of the cystic fibrosis phenotype in a large kindred family in Qatar with cystic fibrosis mutation (I1234V). J Trop Pediatr 47:110–112PubMed
14.
go back to reference Banjar H, Kambouris M, Meyer BF, Al-Mehaidib A, Mogirri I (1999) Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia. Ann Trop Paediatr 19:69–73PubMedCrossRef Banjar H, Kambouris M, Meyer BF, Al-Mehaidib A, Mogirri I (1999) Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia. Ann Trop Paediatr 19:69–73PubMedCrossRef
15.
go back to reference Abdul Wahab A, Abushahin A (2010) Pseudomonas aeruginosa in cystic fibrosis patients with CFTR I1234V in a large kindred family. Qatar Med J 19:28–31 Abdul Wahab A, Abushahin A (2010) Pseudomonas aeruginosa in cystic fibrosis patients with CFTR I1234V in a large kindred family. Qatar Med J 19:28–31
16.
go back to reference Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, Meis JF (2012) Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother 56:2635–2642PubMedCentralPubMedCrossRef Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, Meis JF (2012) Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother 56:2635–2642PubMedCentralPubMedCrossRef
17.
go back to reference Renders NH, Sijmon MA, van Belkum A, Overbreek SE, Mouton JW, Verbrugh HA (1997) Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings. Res Microbiol 148:447–454PubMedCrossRef Renders NH, Sijmon MA, van Belkum A, Overbreek SE, Mouton JW, Verbrugh HA (1997) Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings. Res Microbiol 148:447–454PubMedCrossRef
18.
go back to reference Grothues D, Koopmann U, von der Hardt H, Tümmler B (1988) Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol 26:1973–1977PubMedCentralPubMed Grothues D, Koopmann U, von der Hardt H, Tümmler B (1988) Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol 26:1973–1977PubMedCentralPubMed
19.
go back to reference Wolz C, Kiosz G, Ogle JW, Vasil ML, Schaad U, Botzenhart K, Döring G (1989) Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe. Epidemiol Infect 102:205–214PubMedCrossRef Wolz C, Kiosz G, Ogle JW, Vasil ML, Schaad U, Botzenhart K, Döring G (1989) Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe. Epidemiol Infect 102:205–214PubMedCrossRef
20.
go back to reference Speert DP, Campbell ME, Henry DA, Milner R, Taha F, Gravelle A, Davidson AG, Wong LT, Mahenthiralingam E (2002) Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med 166:988–993PubMedCrossRef Speert DP, Campbell ME, Henry DA, Milner R, Taha F, Gravelle A, Davidson AG, Wong LT, Mahenthiralingam E (2002) Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med 166:988–993PubMedCrossRef
21.
go back to reference Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK (2001) Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358:557–558PubMedCrossRef Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK (2001) Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358:557–558PubMedCrossRef
22.
go back to reference Logan C, Habington A, Lennon G, Grogan J, Byrne M, O’Leary J, O’Sullivan N (2012) Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland. J Med Microbiol 61:64–70PubMedCrossRef Logan C, Habington A, Lennon G, Grogan J, Byrne M, O’Leary J, O’Sullivan N (2012) Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland. J Med Microbiol 61:64–70PubMedCrossRef
23.
go back to reference Van Daele SG, Franckx H, Verhelst R, Schelstraete P, Haerynck F, Van Simaey L, Claeys G, Vaneechoutte M, de Baets F (2005) Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre. Eur Respir J 25:474–481PubMedCrossRef Van Daele SG, Franckx H, Verhelst R, Schelstraete P, Haerynck F, Van Simaey L, Claeys G, Vaneechoutte M, de Baets F (2005) Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre. Eur Respir J 25:474–481PubMedCrossRef
24.
go back to reference Da Silva Filho LV, Levi JE, Bento CN, Rodrigues JC, da Silvo Ramos SR (2001) Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic. J Med Microbiol 50:261–267 Da Silva Filho LV, Levi JE, Bento CN, Rodrigues JC, da Silvo Ramos SR (2001) Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic. J Med Microbiol 50:261–267
25.
go back to reference Hoogkamp-Korstanje JA, Meis JF, Kissing J, van der Laag J, Melchers WJ (1995) Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients. J Clin Microbiol 33:572–575PubMedCentralPubMed Hoogkamp-Korstanje JA, Meis JF, Kissing J, van der Laag J, Melchers WJ (1995) Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients. J Clin Microbiol 33:572–575PubMedCentralPubMed
26.
go back to reference Vosahlikova S, Drevinek P, Cinek O, Pohunek P, Maixnerova M, Urbaskova P, van den Reijden TJ, Dijkshoorn L, Nemec A (2007) High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic. Res Microbiol 158:324–329PubMedCrossRef Vosahlikova S, Drevinek P, Cinek O, Pohunek P, Maixnerova M, Urbaskova P, van den Reijden TJ, Dijkshoorn L, Nemec A (2007) High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic. Res Microbiol 158:324–329PubMedCrossRef
27.
go back to reference Brimicombe RW, Dijkshoorn L, van der Reijden TJ, Kardoes I, Pitt TL, van den Broek PJ, Heijerman HG (2008) Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 7:30–36PubMedCrossRef Brimicombe RW, Dijkshoorn L, van der Reijden TJ, Kardoes I, Pitt TL, van den Broek PJ, Heijerman HG (2008) Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 7:30–36PubMedCrossRef
28.
go back to reference Ballarini A, Scalet G, Kos M, Cramer N, Wiehlmann L, Jousson O (2012) Molecular typing and epidemiological investigation of clinical populations of Pseudomonas aeruginosa using an oligonucleotide-microarray. BMC Microbiol 12:152PubMedCentralPubMedCrossRef Ballarini A, Scalet G, Kos M, Cramer N, Wiehlmann L, Jousson O (2012) Molecular typing and epidemiological investigation of clinical populations of Pseudomonas aeruginosa using an oligonucleotide-microarray. BMC Microbiol 12:152PubMedCentralPubMedCrossRef
29.
go back to reference Kidd TJ, Ramsay KA, Hu H, Marks GB, Wainwright CE, Bye PT, Elkins MR, Robinson PJ, Rose BR, Wilson JW, Grimwood K, Bell SC (2013) Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J 41:1091–1100PubMedCrossRef Kidd TJ, Ramsay KA, Hu H, Marks GB, Wainwright CE, Bye PT, Elkins MR, Robinson PJ, Rose BR, Wilson JW, Grimwood K, Bell SC (2013) Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J 41:1091–1100PubMedCrossRef
30.
go back to reference Waters V, Zlosnik JE, Yau YC, Speert DP, Aaron SD, Guttman DS (2013) Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 31:3341–3350CrossRef Waters V, Zlosnik JE, Yau YC, Speert DP, Aaron SD, Guttman DS (2013) Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 31:3341–3350CrossRef
31.
go back to reference Janssen P, Coopman R, Huys G, Swings J, Bleeker M, Vos P, Zabeau M, Kersters K (1996) Evaluation of the DNA fingerprinting method AFLP as an new tool in bacterial taxonomy. Microbiology 142:1881–1893PubMedCrossRef Janssen P, Coopman R, Huys G, Swings J, Bleeker M, Vos P, Zabeau M, Kersters K (1996) Evaluation of the DNA fingerprinting method AFLP as an new tool in bacterial taxonomy. Microbiology 142:1881–1893PubMedCrossRef
32.
go back to reference Geornaras I, Kunene NF, von Holy A, Hastings JW (1999) Amplified fragment length polymorphism fingerprinting of Pseudomonas strains from a poultry processing plant. Appl Environ Microbiol 65:3828–3833PubMedCentralPubMed Geornaras I, Kunene NF, von Holy A, Hastings JW (1999) Amplified fragment length polymorphism fingerprinting of Pseudomonas strains from a poultry processing plant. Appl Environ Microbiol 65:3828–3833PubMedCentralPubMed
33.
go back to reference Speijer H, Savelkoul PH, Bonten MJ, Stobberingh EE, Tjhie JH (1999) Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 37:3654–3661PubMedCentralPubMed Speijer H, Savelkoul PH, Bonten MJ, Stobberingh EE, Tjhie JH (1999) Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 37:3654–3661PubMedCentralPubMed
34.
go back to reference Renders N, van Belkum A, Bath A, Goessens W, Mouton JW, Verbrugh H (1996) Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotypic versus genotyping. Clin Microbiol Infect 1:261–265PubMed Renders N, van Belkum A, Bath A, Goessens W, Mouton JW, Verbrugh H (1996) Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotypic versus genotyping. Clin Microbiol Infect 1:261–265PubMed
35.
go back to reference McDowell A, Mahenthiralingam E, Dunbar KE, Moore JE, Crowe M, Elborn JS (2004) Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation. J Med Microbiol 53:663–668PubMedCrossRef McDowell A, Mahenthiralingam E, Dunbar KE, Moore JE, Crowe M, Elborn JS (2004) Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation. J Med Microbiol 53:663–668PubMedCrossRef
Metadata
Title
Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting
Authors
A. Abdul Wahab
S. J. Taj-Aldeen
F. Hagen
S. Diophode
A. Saadoon
J. F. Meis
C. H. Klaassen
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2014
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-013-1954-1

Other articles of this Issue 2/2014

European Journal of Clinical Microbiology & Infectious Diseases 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine